🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026 Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs FDA Fires Warning Shot at Sanofi's Irish Plant Over Data Cover-Up and Altuviiio Quality Failings Top Universities in Ireland: Discover the Country's Leading Higher Education Institutions The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation Ireland Funds €426,000 Behavioral App for Alcohol Reduction Amid Record Treatment Demand
Markets · 15 min delay
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
ISEQ9,241.3▲ +0.62%
NBI4,187.6▲ +1.14%
PFE28.42▼ -0.38%
AZN74.18▲ +0.81%
NVO103.55▲ +2.07%
ROG261.40▼ -0.55%
ABBV174.92▲ +0.29%
EUR/USD1.0842▼ -0.12%
Updated 04 Jul 2026 · HPRA open data

Dabigatran etexilate mesilate - Medicines in Ireland

26 authorised products containing Dabigatran etexilate mesilate, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
Showing 26 authorised medicines
MedicineActive substanceLicence holderStatus
Dabigatran Etexilate 110 mg hard capsules
PA0126/386/002
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Marketed
Dabigatran Etexilate 150 mg hard capsules
PA0126/386/003
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Marketed
Dabigatran Etexilate 75 mg hard capsules
PA0126/386/001
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Accord 110 mg hard capsules
EU/1/22/1665/007-016
Dabigatran etexilate mesilate Accord Healthcare S.L.U.
Dabigatran etexilate Accord 150 mg hard capsules
EU/1/22/1665/017-024
Dabigatran etexilate mesilate Accord Healthcare S.L.U.
Dabigatran etexilate Accord 75 mg hard capsules
EU/1/22/1665/001-006
Dabigatran etexilate mesilate Accord Healthcare S.L.U.
Dabigatran etexilate Clonmel 110 mg hard capsules
PA0126/340/002
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Clonmel 150 mg hard capsules
PA0126/340/003
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Clonmel 75 mg hard capsules
PA0126/340/001
Dabigatran etexilate mesilate Clonmel Healthcare Ltd Not marketed
Dabigatran etexilate Gedeon Richter 110 mg hard capsules
PA1330/033/001
Dabigatran etexilate mesilate Gedeon Richter Plc Not marketed
Dabigatran etexilate Gedeon Richter 150 mg hard capsules
PA1330/033/002
Dabigatran etexilate mesilate Gedeon Richter Plc Not marketed
Dabigatran Etexilate Krka 110 mg hard capsules
PA1347/110/002
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 150 mg hard capsules
PA1347/110/003
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Marketed
Dabigatran Etexilate Krka 75 mg hard capsules
PA1347/110/001
Dabigatran etexilate mesilate KRKA, d.d., Novo mesto Not marketed
Dabigatran etexilate Rowa 110 mg hard capsules
PA0074/095/001
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dabigatran etexilate Rowa 150 mg hard capsules
PA0074/095/002
Dabigatran etexilate mesilate Rowa Pharmaceuticals Limited, Not marketed
Dabigatran etexilate Teva 110 mg hard capsules
EU/1/23/1769/007-015
Dabigatran etexilate mesilate TEVA GmbH
Dabigatran etexilate Teva 150 mg hard capsules
EU/1/23/1769/016-023
Dabigatran etexilate mesilate TEVA GmbH
Dabigatran etexilate Teva 75 mg hard capsules
EU/1/23/1769/001-006
Dabigatran etexilate mesilate TEVA GmbH
Pradaxa 110 mg coated granules
EU/1/08/442/0029
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg coated granules
EU/1/08/442/030
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 150 mg hard capsules
EU/1/08/442/009-013
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 20 mg coated granules
EU/1/08/442/025
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 30 mg coated granules
EU/1/08/442/0026
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 40 mg coated granules
EU/1/08/442/0027
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Pradaxa 50 mg coated granules
EU/1/08/442/028
Dabigatran etexilate mesilate Boehringer Ingelheim International GmbH
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.